Favorite 5 Articles from Recent Medical Journals
MS Drugs Are Criminally Expensive Failures
Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis (MS) by Afsaneh Shirani, published in the July 18, 2012 issue of the Journal of the American Medical Association, found that, Among patients with relapsing-remitting MS, administration of interferon beta was not associated with a reduction in progression of disability.” The investigators conclude